Cogent Biosciences, Inc. (COGT) Financials

COGT Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 834.5 million 302.2 million
March 31, 2026 903.0 million 295.3 million
Dec. 31, 2025 937.6 million 301.2 million
Sept. 30, 2025 425.9 million 123.5 million

COGT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -77.6 million 17.1 million
March 31, 2026 -87.3 million 16.9 million
Dec. 31, 2025 -79.9 million 15.8 million
Sept. 30, 2025 -64.4 million 10.6 million

COGT Net Income

No data available :(

COGT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 792.3 million 223.5 million 19.3 million
March 31, 2026 866.4 million 223.2 million 14.1 million
Dec. 31, 2025 900.8 million 237.3 million 14.4 million
Sept. 30, 2025 390.9 million 44.3 million 16.3 million

COGT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 171.0 million
March 31, 2026 170.8 million
Dec. 31, 2025 161.0 million
Sept. 30, 2025 139.8 million

COGT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 370000 70.8 million 31.8 million -
March 31, 2026 449000 75.4 million 28.2 million -
Dec. 31, 2025 811000 74.4 million 23.9 million -
Sept. 30, 2025 65000 69.0 million 14.4 million -

COGT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 1.2 million
Dec. 31, 2025 - 1.2 million
Sept. 30, 2025 - -

COGT

Price: $37.93

52 week price:
10.38
43.73

Earnings Per Share: -2.18 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 528500

Ebitda: -29.7 million

Market Capitalization: 6.8 billion

Links: